Andrea L. Kwa

Use of Tedizolid for the Treatment of Staphylococcus aureus Bacteremia – An off Labelled Indication

L. W. Loo, Andrea L. Kwa, Jenny G. Low & Jaime Chien · International Journal of Medical and Pharmaceutical Case Reports · 2019

Aims: We aim to share our experience in the successful use of tedizolid for the treatment of Staphylococcus aureus bacteremia in two of our patients. Presentation of Cases: Our first patient had methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. The MRSA isolated was...

Open access Research Article 10.9734/ijmpcr/2019/v12i230103

Anidulafungin-induced Hepatotoxicity and Dose Reduction: A Case Report

L. W. Loo, Jocelyn Teo, Tan Thuan Tong, Winnie Lee & Andrea L. Kwa · International Journal of Medical and Pharmaceutical Case Reports · 2015

Anidulafungin, the newest echinocandin antifungal recently approved by the U.S. FDA, is unique among echinocandins as it undergoes biotransformation rather than being metabolized. In general, patients who received anidulafungin demonstrated low rates of adverse events. Hepatotoxi...

Open access Research Article 10.9734/IJMPCR/2016/22272